Study on novel mutations MEF2A gene in Chinese patients with coronary artery disease

Chinese Journal of Medical Genetics

Volumn 23, Issue 3, 2006, Pages 265-268

  Li, Jing ^a   Yang, Jun Guo ^a   Li, Wei ^a   Du, Rong ^a   Gui, Le ^a   Tian, Li ^a   Guo, Qiu Hui ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Sixth Hospital of Wuhan   (China)

Author keywords

Coronary artery disease; Gene mutation; MEF2A gene

Indexed keywords

PROTEIN MEF2A; TRANSCRIPTION FACTOR IIA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA SEQUENCE; GENE DELETION; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CHINA; CORONARY ARTERY DISEASE; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; MYOGENIC REGULATORY FACTORS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 33745322160     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Wang L, Fan C, Topol SE, et al. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science, 2003, 302:1578-1581.
2. Bhagavatula MR, Fan C, Shen GQ, et al. Transcription factor MEF2A mutations in patients with coronary artery disease. Hum Mol Genet, 2004, 13:3181-3188.
3. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation, 1979, 59:607-609.
4. Zhang WM, eds. Experimental enchiridion for modern molecular biology. 1st ed. Beijing: Science Press, 2003. 87-88.
5. Weng L, Kavaslar N, Ustaszewska A, et al. Lack of MEF2A mutations in coronary artery disease. J Clin Invest, 2005, 115:1016-1020.
6. Yu YT. Distinct domains of myocyte enhancer binding factor-2A determining nuclear localization and cell type-specific transcriptional activity. J Biol Chem, 1996, 271:24675-24683.
7. Wang Q, Rao S, Topol EJ. Miscues on the "lack of MEF2A mutations" in coronary artery disease. J Clin Invest, 2005, 115:1399-1400.
8. Priori SG, Napolitano C, Gasparini M, et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families. Circulation, 2000, 102:2509-2515.
9. Black BL, Molkentin JD, Olson EN. Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2. Mol Cell Biol, 1998, 18:69-77.
10. McKinsey TA, Zhang CL, Olson EN. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci, 2002, 27:40-47.